iShares International Treasury Bond ETF vs Revolution Medicines Inc. Common Stock — how do they compare? iShares International Treasury Bond ETF trades at $39.67 (market cap $1.30B), while Revolution Medicines Inc. Common Stock trades at $191.11 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 31× iShares International Treasury Bond ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, iShares International Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares International Treasury Bond ETF for 92 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| IGOV | RVMD | |
|---|---|---|
Market Cap | $1.30B | $40.32B |
Volume | 693,740 | 4,855,734 |
Sector | Fixed Income | Health |
52-Week High | $42.99 | $221.15 |
52-Week Low | $39.65 | $47.50 |
Typical Hold Time | 92 Days | 0 Days |
Enterprise Value | — | $37.02B |
Signals from Pluang's Aura AI — not financial advice
IGOV trades at $39.67, down 0.08% with a bearish technical signal from moving averages, while oscillators are neutral. Key financial ratios are unavailable, limiting fundamental clarity. Recent news highlights rising global bond yields, which may impact interest rate-sensitive stocks.
The outlook is cautious due to missing financial data and bearish technicals. Risks include macroeconomic pressure from higher yields, while opportunities depend on future earnings visibility. Investors need updated financials to assess valuation and growth prospects accurately.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →